Daphna Laifenfeld

Daphna Laifenfeld has a diverse work experience in various leadership positions. Daphna co-founded Genetika+ in 2017 and served as the Chief Scientific Officer. Prior to that, they founded Spacegate LLC in 2011 and held the roles of President, CEO, and Founder. Daphna also worked at Ibex Medical Analytics as the Chief Scientific Officer from 2018 to 2021. Daphna had significant roles at Teva Pharmaceuticals, including Head of Personalized Medicine & Diagnostics and Head of Personalized and Predictive Medicine IL. Daphna also worked as the Director of Personalized Medicine and Pharmacogenomics at Teva Pharmaceutical Industries Ltd Israel. Daphna founded Selventa Israel and was the Global Head of Diagnostics from 2009 to 2013. Daphna'searlier experience includes working as a Team Lead at Genstruct - a Systems Biology and Personalized Medicine company, and as an Instructor at Harvard University.

Daphna Laifenfeld earned their Bachelor's degree in Statistics from the University of Haifa in 1996. Following this, they pursued a Master's degree in Physiological Psychology/Psychobiology, which they completed from Tel Aviv University between 1996 and 1998. Later, they obtained their PhD in Medical Science/Molecular Biology from the Technion - Israel Institute of Technology, completing their doctoral studies between 1999 and 2003.